Recombinant follitropin alfa/lutropin alfa in fertility treatment

References

• SmithMGOn the interruption of pregnancy in the rat by the injection of ovarian follicular extractBull Johns Hopkins Hosp192639420321412255683
   PubMedGoogle Scholar
• FevoldSLHisawFLLeonardSLThe gonad-stimulating and the luteinizing hormones of the anterior lobe of the hypophysisAm J Physiol193197291301
   Web of Science ®Google Scholar
• LunenfeldBHistorical perspectives in gonadotrophin therapyHum Reprod Update200410645346715388674
   PubMed Web of Science ®Google Scholar
• GemzellCADiczfalusyETillingerGClinical effect of human pituitary follicle-stimulating hormone (FSH)J Clin Endocrinol Metab195818121333134813611018
   PubMed Web of Science ®Google Scholar
• LunenfeldBDevelopment of gonadotrophins for clinical useReprod Biomed Online20024Suppl111117
   Google Scholar
• DumbleLJKleinRDCreutzfeldt-Jakob legacy for Australian women treated with human pituitary gonadotropinsLancet199234088238478481357261
   PubMed Web of Science ®Google Scholar
• CochiusJIBurnsRJBlumbergsPCMackKAldermanCPCreutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophinAust NZ J Med1990204592593
   Google Scholar
• StrowitzkiTBiotechnological drugs for reproductive disorders: a review of developmentsBioDrugs19978536037018020526
   PubMed Web of Science ®Google Scholar
• GordonKNew developments in gonadotrophin pharmacologyReprod Biomed Online20025325926412470523
   PubMedGoogle Scholar
• GiudiceLCInsulin-like growth factor family in Graafian follicle development and functionJ Soc Gynecol Investig200181 Suppl ProceedingsS26S29
   Google Scholar
• WolfensonCGroismanJCoutoASBatch-to-batch consistency of human-derived gonadotrophin preparations compared with recombinant preparationsReprod Biomed Online200510444245415901450
   PubMed Web of Science ®Google Scholar
• HowlesCMGenetic engineering of human FSH (Gonal-F)Hum Reprod Update1996221721919079412
   PubMed Web of Science ®Google Scholar
• OlijveWde BoerWMuldersJWvan WezenbeekPMMolecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon)Mol Hum Reprod1996253713829238705
   PubMed Web of Science ®Google Scholar
• AlperMMeyerRDekkersCEzcurraDSchertzJKellyEAssessment of the biopotency of follitropin alfa and lutropin alfa combined in one injection: a comparative trial in Sprague-Dawley ratsReprod Biol Endocrinol20086313618647398
   PubMed Web of Science ®Google Scholar
• Saz-ParkinsonZLópez-CuadradoTBouzaCAmateJMOutcomes of new quality standards of follitropin alfa on ovarian stimulation: meta-analysis of previous studiesBioDrugs2009231374219344190
   PubMed Web of Science ®Google Scholar
• AgostinettoRAdministration of follitropin alfa and lutropin alfa combined in a single injection: a feasibility assessmentReprod Biol Endocrinol20097485219450267
   PubMed Web of Science ®Google Scholar
• http://www.emea.europa.eu/humandocs/PDFs/EPAR/pergoveris/H-714-en1.pdf
   Google Scholar
• PierceJGFaithMRGiudiceLCReeveJRStructure and structure-function relationships in glycoprotein hormonesCiba Found Symp197641225250780075
   PubMedGoogle Scholar
• GordonKPrinsMSchullerKLewinJOne million and countingReprod Biomed Online200613331331416984754
   PubMed Web of Science ®Google Scholar
• GoaKLWagstaffAJFollitropin alpha in infertility: a reviewBioDrugs19989323526018020563
   PubMed Web of Science ®Google Scholar
• WideLBakosOMore basic forms of both human follicle-stimulating hormone and luteinizing hormone in serum at midcycle compared with the follicular or luteal phaseJ Clin Endocrinol Metab19937648858898473400
   PubMed Web of Science ®Google Scholar
• PapandreouMJAsteriaCPetterssonKRoninCBeck-PeccozPConcanavalin A affinity chromatography of human serum gonadotropins: evidence for changes of carbohydrate structure in different clinical conditionsJ Clin Endocrinol Metab1993764100810138473374
   PubMed Web of Science ®Google Scholar
• GreenEDBaenzigerJUAsparagine-linked oligosaccharides on lutropin, follitropin, and thyrotropin. II. Distributions of sulfated and sialylated oligosaccharides on bovine, ovine, and human pituitary glycoprotein hormonesJ Biol Chem1988263136443121612
   PubMed Web of Science ®Google Scholar
• DahlKDStoneMPFSH isoforms, radioimmunoassays, bioassays, and their significanceJ Androl199213111221551802
   PubMedGoogle Scholar
• AndersenANDevroeyPArceJCClinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trialHum Reprod200621123217322716873892
   PubMed Web of Science ®Google Scholar
• LambertARodgersMMitchellRIn-vitro biopotency and glycoform distribution of recombinant human follicle stimulating hormone (Org 32489), Metrodin and Metrodin-HPHum Reprod1995107192819358583012
   PubMed Web of Science ®Google Scholar
• MitchellRBauerfeldCSchaeferFScharerKRobertsonWRLess acidic forms of luteinizing hormone are associated with lower testosterone secretion in men on haemodialysis treatmentClin Endocrinol (Oxf)199441165738050133
   PubMed Web of Science ®Google Scholar
• ChappelSCHeterogeneity of follicle stimulating hormone: control and physiological functionHum Reprod Update199554794879080221
   PubMed Web of Science ®Google Scholar
• ZambranoEOlivaresAMendezJPDynamics of basal and gonadotropin-releasing hormone-releasable serum follicle-stimulating hormone charge isoform distribution throughout the human menstrual cycleJ Clin Endocrinol Metab1995805164716567745013
   PubMed Web of Science ®Google Scholar
• AnobileCJTalbotJAMcCannSJPadmanabhanVRobertsonWRGlycoform composition of serum gonadotrophins through the normal menstrual cycle and in the post-menopausal stateMol Hum Reprod1998476316399701785
   PubMed Web of Science ®Google Scholar
• BishopLANguyenTVSchofieldPRBoth of the beta-subunit carbohydrate residues of follicle-stimulating hormone determine the metabolic clearance rate and in vivo potencyEndocrinology19951366263526407750487
   PubMed Web of Science ®Google Scholar
• DhillonSKeatingGMLutropin alfaDrugs200868111529154018627209
   PubMed Web of Science ®Google Scholar
• LoumayeEEngrandPHowlesCMO’DeaLAssessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcomeFertil Steril19976758898999130895
   PubMed Web of Science ®Google Scholar
• WestonAMZelinski-WootenMBHutchisonJSStoufferRLWolfDPDevelopmental potential of embryos produced by in-vitro fertilization from gonadotrophin-releasing hormone antagonist-treated macaques stimulated with recombinant human follicle stimulating hormone alone or in combination with luteinizing hormoneHum Reprod19961136086138671277
   PubMed Web of Science ®Google Scholar
• Zelinski-WootenMBHutchisonJSHessDLWolfDPStoufferRLFollicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophin-releasing hormone antagonist-treated monkeysHum Reprod1995107165816668582957
   PubMed Web of Science ®Google Scholar
• BurguesSSpanish Collaborative Group on Female Hypogonadotrophic Hypogonadism. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in SpainHum Reprod200116122525253211726569
   PubMed Web of Science ®Google Scholar
• Recombinant LH Study GroupDoes the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding studyHum Reprod200520362963515618252
   PubMed Web of Science ®Google Scholar
• LoumayeEOvarian stimulation: is exogenous LH necessary in all patients?Gynecol Obstet Fertil2002301189089512476696
   PubMedGoogle Scholar
• LoumayeEEngrandPShohamZHillierSGBairdDTClinical evidence for an LH ceiling?Hum Reprod200318122719272014645197
   PubMed Web of Science ®Google Scholar
• LockwoodGMMuttukrishnaSGroomeNPKnightPGLedgerWLCirculating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilization-embryo transferClin Endocrinol (Oxf)19964567417489039341
   PubMed Web of Science ®Google Scholar
• FischBAvrechOMPinkasHSuperovulation before IVF by recombinant versus urinary human FSH (combined with a long GnRH analog protocol): a comparative studyJ Assist Reprod Genet199512126317580006
   PubMed Web of Science ®Google Scholar
• le CotonnecJYLoumayeEPorchetHCBeltramiVMunafoAPharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormoneFertil Steril19986922012099496329
   PubMed Web of Science ®Google Scholar
• KarlssonMOWadeJRLoumayeEMunafoAThe population pharmacokinetics of recombinant- and urinary-human follicle stimulating hormone in womenBr J Clin Pharmacol199845113209489588
   PubMed Web of Science ®Google Scholar
• le CotonnecJYPorchetHCBeltramiVMunafoAClinical pharmacology of recombinant human luteinizing hormone: Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormoneFertil Steril19986921891949496327
   PubMed Web of Science ®Google Scholar
• le CotonnecJYPorchetHCBeltramiVKhanAToonSRowlandMClinical pharmacology of recombinant human follicle-stimulating hormone (FSH). I. Comparative pharmacokinetics with urinary human FSHFertil Steril19946146696788150109
   PubMed Web of Science ®Google Scholar
• BaerGLoumayeEComparison of recombinant human luteinising hormone (r-hLH) and human menopausal gonadotropin (hMG) in assisted reproductive technologyCurr Med Res Opin2003192838812740151
   PubMed Web of Science ®Google Scholar
• SieboldBPhysicochemical characterization of recombinant human follicle stimulating hormoneHum Reprod199611 Suppl11091115 discussion 117–1198671400
   PubMed Web of Science ®Google Scholar
• DriebergenRBaerGQuantification of follicle stimulating hormone (follitropin alfa): is in vivo bioassay still relevant in the recombinant age?Curr Med Res Opin2003191414612661779
   PubMed Web of Science ®Google Scholar
• LispiMBassettRCrisciCComparative assessment of the consistency and quality of a highly purified FSH extracted from human urine (urofollitropin) and a recombinant human FSH (follitropin alpha)Reprod Biomed Online200613217919316895630
   PubMed Web of Science ®Google Scholar
• LassAMcVeighEUK Gonal-f FbM PMS GroupRoutine use of r-hFSH follitropin alfa filled-by-mass for follicular development for IVF: a large multicentre observational study in the UKReprod Biomed Online20049660461015670403
   PubMed Web of Science ®Google Scholar
• WiklandMHuguesJNHowlesCImproving the consistency of ovarian stimulation: follitropin alfa filled-by-massReprod Biomed Online200612666366816792840
   PubMed Web of Science ®Google Scholar
• KeckCBassettRLudwigMFactors influencing response to ovarian stimulationReprod Biomed Online200511556256916409704
   PubMed Web of Science ®Google Scholar
• http://www.fda.gov/cder/foi/label/2004/21322/lbl.pdf
   Google Scholar
• DickeyRPStrategies to reduce multiple pregnancies due to ovulation stimulationFertil Steril200991111718973894
   PubMed Web of Science ®Google Scholar
• Van LoonKSafety of high doses of recombinant human growth hormoneHorm Res199849# Suppl 27881
   Google Scholar
• HuguesJNRecombinant human follicle-stimulating hormone: a scientific step to clinical improvementReprod Biomed Online200121546412537825
   PubMedGoogle Scholar
• Recombinant Human FSH Study GroupClinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilizationFertil Steril199563177867805928
   PubMed Web of Science ®Google Scholar
• BerghCHowlesCMBorgKRecombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniquesHum Reprod19971210213321399402268
   PubMed Web of Science ®Google Scholar
• BalenAPlatteauPAndersenANDevroeyPHelmgaardLArceJCfor the Bravelle Ovulation Induction (BOI) Study GroupHighly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trialHum Reprod20072271816182317449511
   PubMed Web of Science ®Google Scholar
• Loret de MolaJRKiwiRAustinCGoldfarbJMSubclavian deep vein thrombosis associated with the use of recombinant follicle-stimulating hormone (Gonal-F) complicating mild ovarian hyperstimulation syndromeFertil Steril20007361253125610917745
   PubMed Web of Science ®Google Scholar
• BarJOrvietoRLahavJHodMKaplanBFischBEffect of urinary versus recombinant follicle-stimulating hormone on platelet function and other hemostatic variables in controlled ovarian hyperstimulationFertil Steril20048261564156915589861
   PubMed Web of Science ®Google Scholar
• HedonBHuguesJNEmperaireJCA comparative prospective study of a chronic low dose versus a conventional ovulation stimulation regimen using recombinant human follicle stimulating hormone in anovulatory infertile womenHum Reprod19981310268826929804214
   PubMed Web of Science ®Google Scholar
• HarrisonSWolfTAbuzeidMIAdministration of recombinant follicle stimulating hormone in a woman with allergic reaction to menotropin: a case reportGynecol Endocrinol200014314915210923273
   PubMed Web of Science ®Google Scholar
• PhippsWRHoldenDSheehanRKUse of recombinant human follicle-stimulating hormone for in vitro fertilization-embryo transfer after severe systemic immunoglobulin E-mediated reaction to urofollitropinFertil Steril19966611481508752627
   PubMed Web of Science ®Google Scholar
• BrinsdenPAkagbosuFGibbonsLMA comparison of the efficacy and tolerability of two recombinant human follicle-stimulating hormone preparations in patients undergoing in vitro fertilization-embryo transferFertil Steril200073111411610632423
   PubMed Web of Science ®Google Scholar
• OrvietoRNahumRRabinsonJAshkenaziJAntebyEYMeltcerSFollitropin-alpha (Gonal-F) versus follitropin-beta (Puregon) in controlled ovarian hyperstimulation for in vitro fertilization: is there any difference?Fertil Steril2009914 Suppl1522152518851846
   PubMed Web of Science ®Google Scholar
• FriedGHarlinJWramsbyHRecombinant FSH – clinical experience with two different preparationsFertil Steril199870Suppl 1S112
   Google Scholar
• EgbasePESevere OHSS: how many cases are preventable?Hum Reprod200015181010611179
   PubMed Web of Science ®Google Scholar
• AboulgharMEversJHAl-InanyHIntravenous albumin for preventing severe ovarian hyperstimulation syndrome: a Cochrane reviewHum Reprod200217123027303212456597
   PubMed Web of Science ®Google Scholar
• BuyalosRPLeeCTPolycystic ovary syndrome: pathophysiology and outcome with in vitro fertilizationFertil Steril19966511108557121
   PubMed Web of Science ®Google Scholar
• MacDougallMJTanSLBalenAJacobsHSA controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilizationHum Reprod1993822332378473426
   PubMed Web of Science ®Google Scholar
• FormanRGFrydmanREganDRossCBarlowDHSevere ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for preventionFertil Steril19905335025092106456
   PubMed Web of Science ®Google Scholar
• FauserBCVan HeusdenAMManipulation of human ovarian function: physiological concepts and clinical consequencesEndocr Rev1997181711069034787
   PubMed Web of Science ®Google Scholar
• BalaschJFabreguesFPenarrubiaJOutcome from consecutive assisted reproduction cycles in patients treated with recombinant follitropin alfa filled-by-bioassay and those treated with recombinant follitropin alfa filled-by-massReprod Biomed Online20048440841315149563
   PubMed Web of Science ®Google Scholar
• BalaschJPenarrubiaJFabreguesFOvarian responses to recombinant FSH or HMG in normogonadotrophic women following pituitary desensitization by a depot GnRH agonist for assisted reproductionReprod Biomed Online200371354212930572
   PubMedGoogle Scholar
• European and Israeli Study Group on Highly Purified Menotropin versus Recombinant Follicle-Stimulating HormoneEfficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized, comparative trialFertil Steril200278352052812215327
   PubMed Web of Science ®Google Scholar
• Al-InanyHGAbou-SettaAMAboulgharMAMansourRTSerourGIEfficacy and safety of human menopausal gonadotrophins versus recombinant FSH: a meta-analysisReprod Biomed Online2008161818818252052
   PubMed Web of Science ®Google Scholar
• CoomarasamyAAfnanMCheemaDvan der VeenFBossuytPMvan WelyMUrinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysisHum Reprod200823231031518056719
   PubMed Web of Science ®Google Scholar
• MochtarMHVan derVZiechMvan WelyMRecombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cyclesCochrane Database Syst Rev20072CD00507017443569
   PubMed Web of Science ®Google Scholar
• TimevaTMilachichTAntonovaIArabajiTShterevAOmarHACorrelation between number of retrieved oocytes and pregnancy rate after in vitro fertilization/intracytoplasmic sperm infectionScientific WorldJournal20066686690
   Google Scholar
• van RumsteMMCustersIMvan der VeenFvan WelyMEversJLMolBWThe influence of the number of follicles on pregnancy rates in intrauterine insemination with ovarian stimulation: a meta-analysisHum Reprod Update200814656357018687698
   PubMed Web of Science ®Google Scholar
• SedbonEWainerRPervesCQuality of life of patients undergoing ovarian stimulation with injectable drugs in relation to medical practice in FranceReprod Biomed Online200612329830316569316
   PubMed Web of Science ®Google Scholar
• PalermoRDifferential actions of FSH and LH during folliculogenesisReprod Biomed Online200715332633717854533
   PubMed Web of Science ®Google Scholar
• O’DeaLO’BrienFCurrieKHemseyGFollicular development induced by recombinant luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in anovulatory women with LH and FSH deficiency: evidence of a threshold effectCurr Med Res Opin200824102785279318727841
   PubMed Web of Science ®Google Scholar
• KlieschSBehreHMNieschlagERecombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic maleFertil Steril1995636132613287750608
   PubMed Web of Science ®Google Scholar
• ArslanAAGuYZeleniuch-JacquotteAReproducibility of serum pituitary hormones in womenCancer Epidemiol Biomarkers Prev20081781880188318708375
   PubMed Web of Science ®Google Scholar
• DhontMOnghenaACoetsierTDe SutterPProspective randomized study of clomiphene citrate and gonadotrophins versus goserelin and gonadotrophins for follicular stimulation in assisted reproductionHum Reprod19951047917967650122
   PubMed Web of Science ®Google Scholar
• SteuresPvan der SteegJWHompesPGIntra-uterine insemination with controlled ovarian hyperstimulation compared to an expectant management in couples with unexplained subfertility and an intermediate prognosis: a randomised studyNed Tijdschr Geneeskd2008152271525153118681363
   PubMedGoogle Scholar
• BensdorpAJCohlenBJHeinemanMJVandekerckhovePIntra-uterine insemination for male subfertilityCochrane Database Syst Rev200744CD00036017943739
   PubMedGoogle Scholar
• BarlowDHGnRH agonists and in vitro fertilizationJ Reprod Med1998433 Suppl2452519564657
   PubMed Web of Science ®Google Scholar
• SbraciaMColabianchiJGiallonardoACetrorelix protocol versus gonadotropin-releasing hormone analog suppression long protocol for superovulation in intracytoplasmic sperm injection patients older than 40Fertil Steril20099151842184718501900
   PubMed Web of Science ®Google Scholar
• CocciaMEComparettoCBraccoGLScarselliGGnRH antagonistsEur J Obstet Gynecol Reprod Biol2004115Suppl 1S44S5615196716
   PubMed Web of Science ®Google Scholar
• KingslandCTanSLBickertonNMasonBCampbellSThe routine use of gonadotropin-releasing hormone agonists for all patients undergoing in vitro fertilization. Is there any medical advantage? A prospective randomized studyFertil Steril19925748048091555691
   PubMed Web of Science ®Google Scholar
• BroekmansFJBernardusREBerkhoutGSchoemakerJPituitary and ovarian suppression after early follicular and mid-luteal administration of a LHRH agonist in a depot formulation: decapeptyl CRGynecol Endocrinol1992631531611442160
   PubMed Web of Science ®Google Scholar
• AbdallaHIAhujaKKLeonardTMorrisNNHonourJWJacobsHSComparative trial of luteinizing hormone-releasing hormone analog/human menopausal gonadotropin and clomiphene citrate/human menopausal gonadotropin in an assisted conception programFertil Steril19905334734782106453
   PubMed Web of Science ®Google Scholar
• De PlacidoGAlviggiCMolloAStrinaIVarricchioMTMolisMRecombinant follicle stimulating hormone is effective in poor responders to highly purified follicle stimulating hormoneHum Reprod2000151172010611181
   PubMed Web of Science ®Google Scholar
• MohamedMASbraciaMPacchiarottiAUrinary follicle-stimulating hormone (FSH) is more effective than recombinant FSH in older women in a controlled randomized studyFertil Steril20068551398140316600226
   PubMed Web of Science ®Google Scholar
• HompesPGBroekmansFJHoozemansDASchatsRFIRM groupEffectiveness of highly purified human menopausal gonadotropin vs recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patientsFertil Steril20088961685169317681325
   PubMed Web of Science ®Google Scholar
• BoschEVidalCLabartaESimonCRemohiJPellicerAHighly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists – a randomized studyHum Reprod200823102346235118583332
   PubMed Web of Science ®Google Scholar
• ShohamZInslerVRecombinant technique and gonadotropins production: new era in reproductive medicineFertil Steril19966621872018690100
   PubMed Web of Science ®Google Scholar
• TulppalaMAhoMTuuriTComparison of two recombinant follicle-stimulating hormone preparations in in-vitro fertilization: a randomized clinical studyHum Reprod199914112709271510548606
   PubMed Web of Science ®Google Scholar
• HarlinJCsemiczkyGWramsbyHFriedGRecombinant follicle stimulating hormone in in-vitro fertilization treatment-clinical experience with follitropin alpha and follitropin betaHum Reprod200015223924410655291
   PubMed Web of Science ®Google Scholar
• PlatteauPAndersenANBalenAMenopur Ovulation Induction (MOI) Study GroupSimilar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled studyHum Reprod20062171798180416571641
   PubMed Web of Science ®Google Scholar
• KolibianakisEZikopoulosKAlbanoCReproductive outcome of polycystic ovarian syndrome patients treated with GnRH antagonists and recombinant FSH for IVF/ICSIReprod Biomed Online20037331331814653891
   PubMedGoogle Scholar
• WatsonHKiddyDSHamilton-FairleyDHypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriageHum Reprod1993868298338345070
   PubMed Web of Science ®Google Scholar
• OliveiraJBMauriALPetersenCGRecombinant luteinizing hormone supplementation to recombinant follicle-stimulation hormone during induced ovarian stimulation in the GnRH-agonist protocol: a meta-analysisJ Assist Reprod Genet2007242–3677517195098
   PubMed Web of Science ®Google Scholar
• BarrenetxeaGAgirregoikoaJAJimenezMRde LarruzeaALGanzabalTCarboneroKOvarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cyclesFertil Steril200889354655317531989
   PubMed Web of Science ®Google Scholar
• KolibianakisEMKalogeropoulouLGriesingerGAmong patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysisHum Reprod Update200713544545217586849
   PubMed Web of Science ®Google Scholar
• DurnerinCIErbKFlemingRLuveris Pretreatment GroupEffects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulationHum Reprod200823242142618084048
   PubMed Web of Science ®Google Scholar
• PicardMRossierCPapasouliotisOLuganIBioequivalence of recombinant human FSH and recombinant human LH in a fixed 2:1 combination: two phase I, randomised, crossover studiesCurr Med Res Opin20082441199120818348746
   PubMed Web of Science ®Google Scholar
• LachelinGCYenSSHypothalamic chronic anovulationAm J Obstet Gynecol19781307825831147631
   PubMed Web of Science ®Google Scholar
• HomburgROvulation inductionExpert Opin Pharmacother20034111995200414596653
   PubMed Web of Science ®Google Scholar
• FilicoriMFlamigniCCognigniGDellaiPMichelacciLArnoneRIncreased insulin secretion in patients with multifollicular and polycystic ovaries and its impact on ovulation inductionFertil Steril19946222792858034073
   PubMed Web of Science ®Google Scholar
• The ESHRE Capri Workshop GroupAnovulatory infertilityHum Reprod1995106154915537593533
   PubMed Web of Science ®Google Scholar
• ShohamZSmithHYekoTO’BrienFHemseyGO’DeaLRecombinant LH (lutropin alfa) for the treatment of hypogonadotrophic women with profound LH deficiency: a randomized, double-blind, placebo-controlled, proof-of-efficacy studyClin Endocrinol (Oxf)200869347147818485121
   PubMed Web of Science ®Google Scholar
• KaufmannRDunnRVaughnTRecombinant human luteinizing hormone, lutropin alfa, for the induction of follicular development and pregnancy in profoundly gonadotrophin-deficient womenClin Endocrinol (Oxf)200767456356917692110
   PubMed Web of Science ®Google Scholar
• KoustaEWhiteDMPiazziALoumayeEFranksSSuccessful induction ovulation and completed pregnancy using recombinant human luteinizing hormone and follicle stimulating hormone in a woman with Kallmann’s syndromeHum Reprod199611170718671160
   PubMed Web of Science ®Google Scholar
• CampoSCampoVLanzoneATwin pregnancy using recombinant gonadotropins in a woman with hypogonadotropic hypogonadismGynecol Endocrinol2002161273211915578
   PubMed Web of Science ®Google Scholar
• BroekmansFJFauserBCDiagnostic criteria for polycystic ovarian syndromeEndocrine200630131117185786
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop GroupRevised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertil Steril20048111925
   Web of Science ®Google Scholar
• HendriksMLBrouwerJHompesPGHomburgRLambalkCBLH as a diagnostic criterion for polycystic ovary syndrome in patients with WHO II oligo/amenorrhoeaReprod Biomed Online200816676577118549684
   PubMed Web of Science ®Google Scholar
• DonderwinkelPFSchootDCCoelingh BenninkHJFauserBCPregnancy after induction of ovulation with recombinant human FSH in polycystic ovary syndromeLancet199234088259831357394
   PubMed Web of Science ®Google Scholar
• PlatteauPAndersenANBalenAOvulation Induction (MOI) Study Group. Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled studyHum Reprod20062171798180416571641
   PubMed Web of Science ®Google Scholar
• RevelliAPosoFGennarelliGMoffaFGrassiGMassobrioMRecombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysisReprod Biol Endocrinol200643816848893
   PubMed Web of Science ®Google Scholar
• YaraliHBukulmezOGurganTUrinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective randomized studyFertil Steril199972227628110438995
   PubMed Web of Science ®Google Scholar
• YaraliHZeynelogluHBGonadotrophin treatment in patients with polycystic ovary syndromeReprod Biomed Online20048552853715151714
   PubMed Web of Science ®Google Scholar
• FulghesuAMApaRBelosiCRecombinant versus urinary follicle-stimulating hormone in the low-dose regimen in anovulatory patients with polycystic ovary syndrome: a safer and more effective treatmentHorm Res200155522422811740143
   PubMedGoogle Scholar
• BayramNvan WelyMvan Der VeenFRecombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndromeCochrane Database Syst Rev200122CD00212111406034
   PubMedGoogle Scholar
• LopezEGunbyJDayaSParrillaJJAbadLBalaschJOvulation induction in women with polycystic ovary syndrome: randomized trial of clomiphene citrate versus low-dose recombinant FSH as first line therapyReprod Biomed Online20049438239015511336
   PubMed Web of Science ®Google Scholar
• SzilagyiABartfaiGManfaiAKoloszarSPalASzaboILow-dose ovulation induction with urinary gonadotropins or recombinant follicle stimulating hormone in patients with polycystic ovary syndromeGynecol Endocrinol2004181172215106360
   PubMed Web of Science ®Google Scholar
• CristelloFCelaVArtiniPGGenazzaniARTherapeutic strategies for ovulation induction in infertile women with polycystic ovary syndromeGynecol Endocrinol200521634035216390783
   PubMed Web of Science ®Google Scholar
• LeaderAMonofollicular Ovulation Induction Study GroupImproved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low-dose step-up protocol with weekly increments of 25 international units of follicle-stimulating hormoneFertil Steril20068561766177316759926
   PubMed Web of Science ®Google Scholar
• AttiaAMAl-InanyHGGonadotrophins for idiopathic male factor subfertilityCochrane Database Syst Rev200744CD00507117943837
   PubMed Web of Science ®Google Scholar
• McLachlanRIThe endocrine control of spermatogenesisBaillieres Best Pract Res Clin Endocrinol Metab200014334536211097780
   PubMed Web of Science ®Google Scholar
• MiyagawaYTsujimuraAMatsumiyaKTakaoTTohdaAKogaMOutcome of gonadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: a 30-year retrospective studyJ Urol20051732072207515879837
   PubMed Web of Science ®Google Scholar
• KamischkeABehreHMBergmannMSimoniMSchaferTNieschlagERecombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trialHum Reprod19981335966039572419
   PubMed Web of Science ®Google Scholar
• ForestaCSeliceRFerlinAGarollaARecombinant FSH in the treatment of oligozoospermiaExpert Opin Biol Ther20099565966619379121
   PubMed Web of Science ®Google Scholar
• BakirciogluMEErdenHFCirayHNBayazitNBahceciMGonadotrophin therapy in combination with ICSI in men with hypogonadotrophic hypogonadismReprod Biomed Online200715215616017697490
   PubMed Web of Science ®Google Scholar
• LeeKHDiekmanMAMossGEAllrichRDPituitary gonadotropins, hypothalamic gonadotropin-releasing hormone, and testicular traits of boars exposed to natural or supplemental lighting during pubertal developmentBiol Reprod1987365116411693113500
   PubMed Web of Science ®Google Scholar
• Cailleux-BounacerAReznikYCauliezBMenardJFDuparcCKuhnJMEvaluation of endocrine testing of Leydig cell function using extractive and recombinant human chorionic gonadotropin and different doses of recombinant human LH in normal menEur J Endocrinol2008159217117818495695
   PubMed Web of Science ®Google Scholar
• BoulouxPWarneDWLoumayeEEfficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotrophic hypogonadismFertil Steril20027727027311821082
   PubMed Web of Science ®Google Scholar
• LiuPYTurnerLRushfordDMcDonaldJBakerHWConwayAJEfficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient menHum Reprod1999141540154510357972
   PubMed Web of Science ®Google Scholar
• MatsumotoAMSnyderPBhasinSMartinKWeberTWintersSStimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f) long-term treatment in azoospermic men with hypogonadotropic hypogonadism (HH)Fertil Steril2008 [Epub ahead of print]
   Web of Science ®Google Scholar
• OkadaHon behalf of the Japanese MHH study groupRecombinant human follicle-stimulating hormone (r-hFSH, follitropin alfa) is efficacious for induction of spermatogenesis and pregnancy in Japanese men with hypogonadotropic hypogonadismFertil Steril200584Suppl 1S222
   Web of Science ®Google Scholar
• WarneDOkadaHYanoYKoideNHowlesCA combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropinFertil SterilIn press2009
   Web of Science ®Google Scholar
• LiuPYGebskiVJTurnerLConwayAJWishartSMHandelsmanDJPredicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile menHum Reprod20021762563311870114
   PubMed Web of Science ®Google Scholar
• PangSKaplanBKarandeVFollistim Pen Trade Mark COH Study GroupAdministration of recombinant human FSH (solution in cartridge) with a pen device in women undergoing ovarian stimulationReprod Biomed Online20037331932614653893
   PubMedGoogle Scholar
• PangSCA pen injection device for self-administration of recombinant follicle-stimulating hormone for fertility treatmentsExpert Rev Med Devices200521273216293025
   PubMed Web of Science ®Google Scholar
• AghssaMMAzargoonARamezanzadehFBagheriMA comparison of the efficacy, tolerability, and convenience of two formulations of follitropin-alpha in Iranian woman undergoing intracytoplasmic sperm injection cyclesFertil Steril20089041043104818053995
   PubMed Web of Science ®Google Scholar
• PorterRKisselCSaundersHKeckCPatient and nurse evaluation of recombinant human follicle-stimulating hormone administration methods: comparison of two follitropin injection pensCurr Med Res Opin200824372773518230195
   PubMed Web of Science ®Google Scholar
• DayaSLedgerWAurayJPCost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UKHum Reprod200116122563256911726575
   PubMed Web of Science ®Google Scholar
• HatoumHTKeyeWRJrMarrsRPWaltonSMMarshallDCA Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial dataFertil Steril200583380480715749525
   PubMed Web of Science ®Google Scholar
• SykesDOutHJPalmerSJvan LoonJThe cost-effectiveness of IVF in the UK: a comparison of three gonadotrophin treatmentsHum Reprod200116122557256211726574
   PubMed Web of Science ®Google Scholar
• ForestaCSeliceRFerlinAGarollaARecombinant FSH in the treatment of oligozoospermiaExpert Opin Biol Ther20099565966619379121
   PubMed Web of Science ®Google Scholar
• LloydAKennedyRHutchinsonJSawyerWEconomic evaluation of highly purified menotropin compared with recombinant follicle-stimulating hormone in assisted reproductionFertil Steril20038051108111314607557
   PubMed Web of Science ®Google Scholar
• WechowskiJConnollyMMcEwanPKennedyRAn economic evaluation of highly purified HMG and recombinant FSH based on a large randomized trialReprod Biomed Online200715550050618028739
   PubMed Web of Science ®Google Scholar
• Al-InanyHAboulgharMAMansourRTProctorMRecombinant versus urinary gonadotrophins for triggering ovulation in assisted conceptionHum Reprod20052082061207316024539
   PubMed Web of Science ®Google Scholar
• Al-InanyHGAbou-SettaAMAboulgharMAMansourRTSerourGIHMG versus rFSH for ovulation induction in developing countries: a cost-effectiveness analysis based on the results of a recent meta-analysisReprod Biomed Online200612216316916478578
   PubMed Web of Science ®Google Scholar
• GerliSCasiniMLUnferVCostabileLBiniVDi RenzoGCRecombinant versus urinary follicle-stimulating hormone in intra-uterine insemination cycles: a prospective, randomized analysis of cost effectivenessFertil Steril200482357357815374698
   PubMed Web of Science ®Google Scholar
• GerliSBiniVDi RenzoGCCost-effectiveness of recombinant follicle-stimulating hormone (FSH) versus human FSH in intrauterine insemination cycles: a statistical model-derived analysisGynecol Endocrinol2008241182318224540
   PubMed Web of Science ®Google Scholar
• Shetty A Disorders of ovulationTempletonAAManagement of Infertility for the MRCOG and BeyondLondonRCOG press2001
   Google Scholar
• WestergaardLGErbKLaursenSBRexSRasmussenPEHuman menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized studyFertil Steril200176354354911532479
   PubMed Web of Science ®Google Scholar
• NgEHLauEYYeungWSHoPCHMG is as good as recombinant human FSH in terms of oocyte and embryo quality: a prospective randomized trialHum Reprod200116231932511157827
   PubMed Web of Science ®Google Scholar
• GordonUDHarrisonRFFawzyMHennellyBGordonACA randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcomeFertil Steril200175232433111172834
   PubMed Web of Science ®Google Scholar
• KilaniZDakkakAGhunaimSA prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomesHum Reprod20031861194119912773445
   PubMed Web of Science ®Google Scholar
• Nyboe AndersenADevroeyPArceJ-Cfor the MERIT GroupClinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trialHum Reprod200621123217322716873892
   PubMed Web of Science ®Google Scholar
• Coelingh BenninkHJFauserBCOutHJRecombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study GroupFertil Steril199869119259457926
   PubMed Web of Science ®Google Scholar
• LoumayeEMartineauIPiazziAClinical assessment of human gonadotrophins produced by recombinant DNA technologyHum Reprod199611 Suppl195107 discussion 117–119
   Google Scholar